Prescient Neuropharma Inc. announces stock option re-pricing


    VANCOUVER, Jan. 7 /CNW/ - Prescient Neuropharma Inc. (the "Company")
reports that pursuant to the Company's Stock Option Plan, a total of 4,200,000
stock options have been re-priced to $0.10 per share. All other original terms
pertaining to the option agreements will remain unchanged.
    850,000 of the options are issued to insiders of the Company and will be
subject to regulatory and disinterested shareholder approval.

    On behalf of Prescient Neuropharma Inc.

    "Gordon Keep"

    Gordon Keep
    President and Director

        The TSX Venture Exchange has not reviewed and does not accept
             responsibility for the adequacy or accuracy of the
                        content of this news release.

For further information:

For further information: Gordon Keep, President, Tel: (604) 609-6110

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890